Ibex Wealth Advisors Has $8.96 Million Stock Position in CME Group Inc. $CME

Ibex Wealth Advisors lessened its position in shares of CME Group Inc. (NASDAQ:CME) by 6.6% in the third quarter, according to its most recent filing with the SEC. The firm owned 33,166 shares of the financial services provider’s stock after selling 2,362 shares during the quarter. CME Group makes up approximately 0.9% of Ibex Wealth Advisors’ investment portfolio, making the stock its 28th largest holding. Ibex Wealth Advisors’ holdings in CME Group were worth $8,961,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in CME Group by 0.4% during the third quarter. Vanguard Group Inc. now owns 35,307,074 shares of the financial services provider’s stock worth $9,539,618,000 after acquiring an additional 130,698 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of CME Group by 3.6% in the 2nd quarter. Geode Capital Management LLC now owns 9,178,681 shares of the financial services provider’s stock valued at $2,524,271,000 after buying an additional 319,899 shares during the period. Norges Bank acquired a new position in CME Group during the 2nd quarter worth approximately $1,571,447,000. Ameriprise Financial Inc. boosted its holdings in CME Group by 2.0% in the second quarter. Ameriprise Financial Inc. now owns 4,682,066 shares of the financial services provider’s stock worth $1,289,910,000 after acquiring an additional 92,925 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its position in CME Group by 6.6% in the second quarter. Arrowstreet Capital Limited Partnership now owns 3,833,090 shares of the financial services provider’s stock worth $1,056,476,000 after purchasing an additional 238,522 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

CME Group stock opened at $319.50 on Friday. CME Group Inc. has a 1-year low of $248.53 and a 1-year high of $322.57. The company has a current ratio of 1.03, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $115.21 billion, a PE ratio of 28.63, a price-to-earnings-growth ratio of 3.70 and a beta of 0.27. The firm’s 50 day simple moving average is $287.63 and its 200 day simple moving average is $275.97.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.64 billion. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The business’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same period in the previous year, the business earned $2.52 EPS. As a group, analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Investors of record on Tuesday, March 10th will be given a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.6%. This is a positive change from CME Group’s previous quarterly dividend of $1.25. The ex-dividend date is Tuesday, March 10th. CME Group’s dividend payout ratio (DPR) is currently 44.80%.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME reported record 2025 results: $6.5B in revenue, AD volume rose 6% to 28.1M contracts (commodities +12%, financials +5%), highlighting continued franchise growth and fee-related revenue strength. This earnings strength is the primary bullish catalyst. CME Group (CME) Achieves Record 2025 Results with $6.5B in Revenue
• Positive Sentiment: CME expanded physical-market infrastructure by approving the first aluminium warehousing facility in Taiwan, supporting commodities product growth and global market access for metals. That strengthens long-term fees and product diversification. CME approves first aluminium warehousing in Taiwan
• Neutral Sentiment: Intraday data and flow reports show mixed signals: QuiverQuant flagged heavy volume and both insider selling and sizable institutional position changes (some managers added, some trimmed). This suggests active rebalancing rather than a clear directional bet. $CME stock is up 2% today. Here’s what we see in our data.
• Neutral Sentiment: Reported short-interest data in the feed appears anomalous (zeros/NaN). No clear short-pressure signal is evident from that entry, so it shouldn’t be driving meaningful price moves. (Treat as data glitch/unreliable.)
• Negative Sentiment: CME experienced a brief technical glitch that halted metals and natural gas trading on Globex and briefly pressured the stock when markets reacted; trading was subsequently restarted. Operational reliability concerns can weigh on near-term sentiment until fully resolved. CME Group halts metals and natural gas trading on technical issues
• Negative Sentiment: Commentary criticizing CME’s Variable Storage Rate program (commodity storage economics) may pressure sentiment among some commodities market participants; impact is likely niche but could attract headlines. Why I Hate Variable Storage Rates

Wall Street Analyst Weigh In

A number of research firms recently commented on CME. Barclays lifted their price target on shares of CME Group from $304.00 to $312.00 and gave the stock an “equal weight” rating in a report on Thursday, February 5th. Piper Sandler increased their price target on CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. The Goldman Sachs Group upped their price objective on shares of CME Group from $264.00 to $266.00 and gave the company a “sell” rating in a report on Monday, February 9th. Jefferies Financial Group cut their target price on shares of CME Group from $304.00 to $302.00 and set a “buy” rating for the company in a research report on Monday, January 12th. Finally, TD Cowen boosted their price target on shares of CME Group from $305.00 to $328.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Nine research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $299.53.

Insiders Place Their Bets

In other CME Group news, Director Dennis Suskind sold 748 shares of the business’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $300.00, for a total value of $224,400.00. Following the completion of the transaction, the director owned 2,699 shares of the company’s stock, valued at $809,700. The trade was a 21.70% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director William R. Shepard bought 251 shares of the business’s stock in a transaction that occurred on Tuesday, December 30th. The stock was bought at an average price of $278.37 per share, with a total value of $69,870.87. Following the completion of the transaction, the director directly owned 258,710 shares of the company’s stock, valued at $72,017,102.70. This represents a 0.10% increase in their position. The SEC filing for this purchase provides additional information. Insiders sold a total of 30,248 shares of company stock valued at $8,355,450 over the last three months. Corporate insiders own 0.30% of the company’s stock.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.